{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:57:16Z","timestamp":1777532236713,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL098370"],"award-info":[{"award-number":["K23HL098370"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["L30HL093896"],"award-info":[{"award-number":["L30HL093896"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","onlinecjc.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cjca.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T03:55:42Z","timestamp":1464926142000},"page":"1478-1484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy\u2014The BIOCRT Study"],"prefix":"10.1016","volume":"32","author":[{"given":"Jonathan","family":"Beaudoin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagmeet P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Szymonifka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh A.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2016.05.013_bib1","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.013_bib2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.CIR.102.12.1400","article-title":"Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study","volume":"102","author":"Yiu","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.013_bib3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.110.009803","article-title":"Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk","volume":"124","author":"van Bommel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.013_bib4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.amjcard.2004.07.154","article-title":"Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure","volume":"94","author":"Lancellotti","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0735-1097(02)02937-6","article-title":"Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure","volume":"41","author":"Breithardt","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2009.03.060","article-title":"Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation","volume":"104","author":"Sitges","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCIMAGING.111.966580","article-title":"Impact of mitral regurgitation on reverse remodeling and outcome in patients undergoing cardiac resynchronization therapy","volume":"5","author":"Verhaert","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.013_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.112.000112","article-title":"Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome","volume":"6","author":"Onishi","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2008.04.036","article-title":"Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial","volume":"52","author":"Cleland","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cardfail.2008.06.001","article-title":"Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial","volume":"14","author":"Uretsky","year":"2008","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/eurheartj\/ehn063","article-title":"Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy","volume":"29","author":"Ypenburg","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2016.05.013_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCIMAGING.108.823732","article-title":"Mechanism of decrease in mitral regurgitation after cardiac resynchronization therapy: optimization of the force-balance relationship","volume":"2","author":"Solis","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.013_bib13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1540-8175.2008.00823.x","article-title":"Reduction in mitral regurgitation in patients undergoing cardiac resynchronization treatment: assessment of predictors by two-dimensional radial strain echocardiography","volume":"26","author":"Goland","year":"2009","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjca.2016.05.013_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.amjcard.2011.06.052","article-title":"Relation between left ventricular morphology and reduction in functional mitral regurgitation by cardiac resynchronization therapy in patients with idiopathic dilated cardiomyopathy","volume":"108","author":"Matsumoto","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","article-title":"Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure","volume":"8","author":"Motiwala","year":"2015","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.cjca.2016.05.013_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurjhf\/hfs180","article-title":"Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study","volume":"15","author":"Weiner","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib17","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.hrthm.2014.07.007","article-title":"Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study","volume":"11","author":"Truong","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2016.05.013_bib18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurjhf\/hft075","article-title":"Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"15","author":"Motiwala","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2016.05.013_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ejechocard\/jep184","article-title":"Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy","volume":"11","author":"Cabrera-Bueno","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjca.2016.05.013_bib22","first-page":"826","article-title":"Reduced mitral regurgitation in heart failure patients submitted to cardiac resynchronization therapy: a short-term prospective study","volume":"5","author":"Zanon","year":"2004","journal-title":"Ital Heart J"},{"key":"10.1016\/j.cjca.2016.05.013_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0300-8932(10)70249-9","article-title":"Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure","volume":"63","author":"Bayes-Genis","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.healun.2008.02.018","article-title":"Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices","volume":"27","author":"Milting","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2016.05.013_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","article-title":"Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial","volume":"14","author":"Lopez-Andres","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cardfail.2014.07.018","article-title":"Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)","volume":"20","author":"Stolen","year":"2014","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-7120-7-39","article-title":"Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy","volume":"7","author":"Magne","year":"2009","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.cjca.2016.05.013_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijcard.2015.02.019","article-title":"Biomarker-assist score for reverse remodeling prediction in heart failure: the ST2-R2 score","volume":"184","author":"Lupon","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.013_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/eurjhf\/hfs205","article-title":"Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT","volume":"15","author":"Anand","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.013_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jchf.2015.07.015","article-title":"Prognostic value of baseline and changes in circulating soluble ST2 levels and the effects of nesiritide in acute decompensated heart failure","volume":"4","author":"Tang","year":"2016","journal-title":"JACC Heart Fail"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16301258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16301258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:26:34Z","timestamp":1668695194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X16301258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0828282X16301258"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2016.05.013","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy\u2014The BIOCRT Study","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}